The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I dose escalation trial of PT2385, a first-in-class oral HIF-2a inhibitor, in patients with advanced clear cell renal cell carcinoma.
 
Kevin Dale Courtney
Stock and Other Ownership Interests - Regeneron (I)
Consulting or Advisory Role - Sanofi
Research Funding - Aragon Pharmaceuticals; Astellas Pharma; Astellas Pharma; Lilly; Medivation; PSMA Development Company
Patents, Royalties, Other Intellectual Property - My spouse receives patent royalties from Athena Diagnostics, Inc. (I)
 
Jeffrey R. Infante
No Relationships to Disclose
 
Elaine Tat Lam
Research Funding - Peloton Therapeutics (Inst)
 
Robert A. Figlin
Consulting or Advisory Role - Novartis; Pfizer
Research Funding - Argos Therapeutics (Inst); Bristol-Myers Squibb (Inst); Cerulean Pharma (Inst); Exelixis (Inst); Immatics (Inst); Peloton Therapeutics (Inst)
 
Brian I. Rini
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Immatics (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer
 
James Brugarolas
Consulting or Advisory Role - Bethyl Laboratories
Research Funding - Peloton Therapeutics
Patents, Royalties, Other Intellectual Property - Peloton Therapeutics
 
Naseem J. Zojwalla
Employment - Peloton Therapeutics
Leadership - Peloton Therapeutics
Stock and Other Ownership Interests - Peloton Therapeutics
 
Keshi Wang
Employment - Peloton Therapeutics
Stock and Other Ownership Interests - Peloton Therapeutics
 
Eli Wallace
Employment - Peloton Therapeutics
Leadership - Peloton Therapeutics
Stock and Other Ownership Interests - Peloton Therapeutics
 
John A. Josey
Employment - Peloton Therapeutics
Leadership - Peloton Therapeutics
Stock and Other Ownership Interests - Peloton Therapeutics
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Foundation Medicine; GlaxoSmithKline; Merck; Novartis; Pfizer; Prometheus; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); TRACON Pharma (Inst)